These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11299425)

  • 1. Determination of soluble ICAM-1 and TNFalphaR in the cerebrospinal fluid and serum levels in a population of Brazilian patients with relapsing-remitting multiple sclerosis.
    Alves-Leon SV; Batista E; Papais-Alvarenga R; Quírico-Santos T
    Arq Neuropsiquiatr; 2001 Mar; 59(1):18-22. PubMed ID: 11299425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
    Elovaara I; Ukkonen M; Leppäkynnäs M; Lehtimäki T; Luomala M; Peltola J; Dastidar P
    Arch Neurol; 2000 Apr; 57(4):546-51. PubMed ID: 10768630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
    Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
    Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cladribine on soluble adhesion molecules in multiple sclerosis.
    Mitosek-Szewczyk K; Stelmasiak Z; Bartosik-Psujek H; Belniak E
    Acta Neurol Scand; 2010 Dec; 122(6):409-13. PubMed ID: 20175758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
    Witkowska AM; Socha K; Kochanowicz J; Karpińska E; Jakoniuk M; Zujko ME; Wilkiel M; Borawska MH; Mariak Z
    Biol Res Nurs; 2016 Jan; 18(1):113-9. PubMed ID: 25911236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index.
    Acar G; Idiman F; Kirkali G; Ozakbaş S; Oktay G; Cakmakçi H; Idiman E
    J Neurol; 2005 Feb; 252(2):146-50. PubMed ID: 15729518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD45RA+ ICAM-3+ lymphocytes in cerebrospinal fluid and blood as markers of disease activity in patients with multiple sclerosis.
    Kraus J; Oschmann P; Engelhardt B; Stolz E; Kuehne BS; Laske C; Schaefer C; Traupe H; Kaps M
    Acta Neurol Scand; 2000 Nov; 102(5):326-32. PubMed ID: 11083511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of transforming growth factor-beta in relapsing-remitting multiple sclerosis.
    Carrieri PB; Provitera V; Bruno R; Perrella M; Tartaglia G; Busto A; Perrella O
    Neurol Res; 1997 Dec; 19(6):599-600. PubMed ID: 9427959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity.
    Kraus J; Oschmann P; Engelhardt B; Bauer R; Schiel C; Kern A; Stolz E; Traupe A; Dorndorf W
    Acta Neurol Scand; 2000 Feb; 101(2):135-9. PubMed ID: 10685862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
    Blauth K; Zhang X; Chopra M; Rogan S; Markovic-Plese S
    Clin Immunol; 2015 Apr; 157(2):121-32. PubMed ID: 25596452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone.
    Franciotta D; Piccolo G; Zardini E; Bergamaschi R; Cosi V
    Acta Neurol Scand; 1997 May; 95(5):275-9. PubMed ID: 9188901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse.
    Rieckmann P; Martin S; Weichselbraun I; Albrecht M; Kitze B; Weber T; Tumani H; Broocks A; Lüer W; Helwig A
    Neurology; 1994 Dec; 44(12):2367-72. PubMed ID: 7527508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of interleukin-1beta and soluble intercellular adhesion molecule-1 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis.
    Mehta PD; Kulczycki J; Mehta SP; Coyle PK; Wisniewski HM
    J Infect Dis; 1997 Mar; 175(3):689-92. PubMed ID: 9041345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of sTNFR-1 and sFas in patients with relapsing-remitting multiple sclerosis.
    Bilińska M; Frydecka I; Podemski R; Gruszka E
    Med Sci Monit; 2002 Oct; 8(10):CR720-3. PubMed ID: 12388926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines and intrathecal IgG synthesis in multiple sclerosis patients during clinical remission.
    Brandão CO; Ruocco HH; Farias Ados S; Oliveira C; Hallal-Longo DE; Mirandola SR; Oliveira EC; Cendes F; Damasceno BP; Santos LM
    Arq Neuropsiquiatr; 2005 Dec; 63(4):914-9. PubMed ID: 16400404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial analysis of soluble intercellular adhesion molecule-1 level in relapsing-remitting multiple sclerosis patients during IFN-beta1b treatment.
    Kilinc M; Saatci-Cekirge I; Karabudak R
    J Interferon Cytokine Res; 2003 Mar; 23(3):127-33. PubMed ID: 12716484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
    Yuceyar N; Taşkiran D; Sağduyu A
    Clin Neurol Neurosurg; 2001 Dec; 103(4):206-11. PubMed ID: 11714562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
    Fainardi E; Castellazzi M; Bellini T; Manfrinato MC; Baldi E; Casetta I; Paolino E; Granieri E; Dallocchio F
    Mult Scler; 2006 Jun; 12(3):294-301. PubMed ID: 16764342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.